0003-3170

S0003-31702020000600001

10.20960/angiologia.00214

España

Spain

España

00 00 2020

72 spe1 1 30

2016 37

2315-81

2016 90

e1-e24

2020 27 2 2

181-205

GBD 2017 Mortality Collaborators

2018 392

1684-735

2017 Edition 2017

Instituto Nacional de Estadística

2018 151

171-90

2020 73

194-6

American Heart Association Strategic Planning Task Force and Statistics Committee

2010 121

586-613

2020 73

205-21

2003 24

987-1003

2018 71

274-82

2019 36

184-92

2019 72

562-8

2003 56 3 3

253-61

2007 61

40-7

2014 61

66-74

2019 72

562-8

2020 41

1190-9

2019 40

2899-906

2018 320

281-97

2019 140

e596-646

2016 37

561-7

2018 11

2017 70

763-9

2019

2017 24

1371-80

2018 137

e15-28

2017 357

the SCOTHEART Investigators

2018 379

924-33

2018 61

599-606

2018 61

1055-63

2019 139

2228-37

2018 61

607-15

2015 3

198-206

DCCT/EDIC Research Group

2017 60

2084-91

The Diabetes Control and Complications trial/Epidemiology of Diabetes Interventions and Complications Research Group

2016 65

1370-9

2014 37

1972-82

2005 353

2643-53

2018 392

477-86

American Diabetes Association. 10

2019 42 Suppl.1 Suppl.1

S103-23

ESC Scientific Document Group

2020 41

255-323

ESC Scientific Document Group

2020 41

111-88

GBD Chronic Kidney Disease Collaboration

2020 395

709-33

2019 39

29-34

2020 141

e139-596

2018 71

e127-248

2018 ESC/ESH guidelines for the management or arterial hypertension

2018 29

3021-104

2020 41

111-88

American Diabetes Association. 11

2020 43 Suppl.January Suppl.January

S135-51

Kidney Disease:Improving Global Outcomes (KDIGO) CKD Work Group

2013 3

1-150

2010 375

2073-81

2015 3

514-25

2019 25

1753-60

National Institute for Health Care Excellence 2016

2014 129 Suppl.2 Suppl.2

S49-73

2017 17

2014 8

2019 142

83-90

investigadores del estudio ZACARIS

2007 60

1250-6

2020 73

290-9

FH expert working group

2017 26

25-35

EAS Familial Hypercholesterolaemia Studies Collaboration

2018 277

234-55

2019 36

199-212

United Nation

2019 67

2560-7

2010 28

1366-72

2017 17

234

2018 39

2019 124

1045-60

2016 315

2673-82

en nombre del Grupo de Trabajo de Hipertensión Arterial y Enfermedad Cardiovascular de SEMERGEN; Miembros del Grupo de Trabajo de Hipertensión Arterial y Enfermedad Cardiovascular de SEMERGEN

2019 45

251-72

2018 218

74-88

Cholesterol Treatment Trialist's Collaboration

2019 393

407-15

2017 65

2362-8

2018 362

2019 40

3516-25

2020 41

12-85

2017 24

1735-45

2019

2018 391

1830-41

2018 104

1069-75

2017 103

492-8

2017 135

e146-603

2019 393

447-92

GBD 2017 Diet Collaborators

2019 393

1958-72

World Health Organization

2015

2017

2019 12

244-58

2019 66

46-7

2019 17

Organización Mundial de la Salud 2010

2018 L303 L303

69-91

EU Science Hub. The European Commission's science and knowledge service. Health promotion and disease prevention 2019

2018 10

1542

2018 3

164

en nombre del Grupo de Nutrición de la Sociedad Española de Epidemiología

2019 33

584-92

Alianza por una Alimentación Saludable

100

2009 41

998-1005

101

2013 8

102

2020 27

758-66

103

2016 388

1302-10

104

2011 57

1604-10

105

2013 28

330-58

106

2001

6963-70

107

World Health Organization 2019

108

U.S. Department of Health and Human Services

2018 320

2020-8

109

Office of Disease Prevention and Health Promotion 2019

110

2015 124

246-56

111

112

2019

113

World Health Organization

114

2019 295

29-35

115

2017

116

2019 365

l2287-12287

117

2016 93

189-97

118

2017 2

e166-74

119

IASLC Lung Cancder News

120

2010 121

2331-78

121

2019 381

705-15

122

2019 40

1590-6

123

2018 250

35-42

124

2015 137

136-40

125

2012 47

107-14

126

2018 15

432-8

127

Ministerio de Agricultura y Pesca, Alimentación y Medio Ambiente

128

2016 23

1658-68

129

2017 32

E9-E23

130

2006 333

131

2018 6

132

2017 4

133

2019 51

1270-81

134

2019 51

1340-53

135

136

2019 51

1220-6

137

Office of Disease Prevention and Health Promotion

138

2016 10

50-66

139

2016 316

1161-71

140

National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health 2014

141

Grupo de Educación sanitaria y promoción de la salud PAPPS

142

2013 382

1629

143

2018 41

1526-34

144

2017 5

774-87

145

2017 105

57-69

146

2015 12

576-87

147

2018 391

1513-23

148

FOURIER Steering Committee and Investigators

2017 376

1713-22

149

Odyssey outcomes Committees and Investigators

2018 379

2097-107

150

SPIRE Cardiovascular Outcome Investigators

2017 376

1527-39

151

2018 137

338-50

152

2019 74

1167-76

153

2019 139

1483-92

154

2020 75

133-44

155

2016 316

2373-84

156

2018 20

1391-8

157

2017 377

633-43

158

2018 39

374-81

159

2018 12

728-33

160

2018 24

3658-64

161

2018 39

2546-50

162

2017 318

748-50

163

2019 31

128-39

164

2017 92

15-29

165

2018 7 7 7

166

2014 24

470-5

167

2006 296

1885-9

168

REDUCE-IT Investigators

2019 380

11-22

169

REDUCE-IT Investigators

2019 74

1159-61

170

2019 284

245-52

171

Finish Diabetes Prevention Study Group

2001 344

1343-50

172

The Look Ahead Research Group

2010 170

1566-75

173

2015 115

1447-63

174

2018 391

541-51

175

2019 139

2022-31

176

Management of Hyperglycemia in Type 2 Diabetes, 2018

2018 41 12 12

2669-701

177

ESC Scientific Document Group

2020 41 1 1

111-88

178

2019 37

1392-400

179

2018 35

97-100

180

2019 37

426-31

181

2020 37

63-5

182

The SPRINT Research Group

2015 373

2103-16

183

2017 130

707-19

184

2019 37

16-23

185

2019 394

1231-42

186

Antithrombotic trialists'(ATT) collaboration

2009 373

1849-60

187

2008 121 1 1

43-9

188

2019

189

2018 392

1036-46

190

ASCEND Study Collaborative Group

2018 379

1529-39

191

2018 379

1509-18

192

2019 171 8 8

529-39

193

2019 26

1035-49

194

2018 80

742-53

195

2009 361

1139-51

196

2011 365

883-91

197

2011 365

981-92

198

2013 369

2093-104

199

2016 375

2423-34

200

2017 377

1513-24

201

2019 394

1335-43

202

2018 39

213-60

203

2018 80

742-53

204

Secondary prevention in the clinical management of patients with cardiovascular diseases

2014 21

664-81

205

2019 26

824-35

206

Euroaspire investigators

2018 25

1242-51

207

2018 39

2365-7

208

2018 55

246-63

209

2016 3

3-10

210

2018 363

211

2013 369

11-9

212

2018 379

215-25

213

2018 71

1814-37

214

2017 3

215

2015 313

1240-8

216

2014 383

333

217

2004 364

331-7

218

2011 6

3-9

219

2019 124

627-35

220

2020

221

E nombre del C ad hoc de las G de E de EC de la SE de N

2020

222

2020 51

1231-9

223

2020 382

9-19

224

2015 372

2387-97

225

2017 376

1713-22

226

2018 379

2097-107

227

2017 136

2440-50

228

2020 51

1546-54

229

2020 8

36-49

230

2019 58

S1-S109

231

2018 320

281-97

232

2018 391

219-29

233

2016 67

2719-28

234

2018 137

338-50

235

2018 73

222-9

236

2019 18

260-71

237

2018 25

505-21

238

2019 26

1775-7